Table 5.

Illustrative Quotes of Subtheme 1d, How Does Quality of Life Factor in to This?

Respondent	Quote
Respondent 12	I kind of take into account, is my patient enjoying the life that they’re living a lot? Like are they partaking in all the things that they want to partake in? If they are really enjoying it, I wouldn’t want them to go through a treatment if I thought it would harm them, but if I think the treatment would benefit them and the disease would harm them, then I would want them to go through it. For my more fragile patients, I usually don’t [bring up LCS]. Like if they have many other comorbidities and their quality of life is already pretty poor, then I usually don’t. In people, whose quality of life I think can be improved, then, yes, I definitely do.
Respondent 13	I have a patient that is in her late 50s, early 60s, with pretty advanced diabetes. She is status-post BKA. The other leg isn’t doing that well either, advanced kidney disease, name it, she has it. We feel her quality of life is pretty difficult, and she doesn’t really get around much. She kind of just like stays at home. She already is kind of miserable and everything. I don’t know if she would really benefit [from LCS] as much. Like I would talk to her about [LCS], but I think the treatment might be really difficult for her on top of everything else. I have like a 75-year-old, or like early mid-70s patient that still goes running every day, spends lots of time with his family, enjoys cooking. He is very involved in like movies and the arts, and tries to keep really busy. So, for him, for example, even if he did have CAD, diabetes, CKD and he was a smoker, he has a pretty good quality of life and he appears very well for his age. So, I would still recommend [LCS] to him.

Respondent

Quote

Respondent 12

I kind of take into account, is my patient enjoying the life that they’re living a lot? Like are they partaking in all the things that they want to partake in? If they are really enjoying it, I wouldn’t want them to go through a treatment if I thought it would harm them, but if I think the treatment would benefit them and the disease would harm them, then I would want them to go through it.
For my more fragile patients, I usually don’t [bring up LCS]. Like if they have many other comorbidities and their quality of life is already pretty poor, then I usually don’t. In people, whose quality of life I think can be improved, then, yes, I definitely do.

Respondent 13

I have a patient that is in her late 50s, early 60s, with pretty advanced diabetes. She is status-post BKA. The other leg isn’t doing that well either, advanced kidney disease, name it, she has it. We feel her quality of life is pretty difficult, and she doesn’t really get around much. She kind of just like stays at home. She already is kind of miserable and everything. I don’t know if she would really benefit [from LCS] as much. Like I would talk to her about [LCS], but I think the treatment might be really difficult for her on top of everything else.
I have like a 75-year-old, or like early mid-70s patient that still goes running every day, spends lots of time with his family, enjoys cooking. He is very involved in like movies and the arts, and tries to keep really busy. So, for him, for example, even if he did have CAD, diabetes, CKD and he was a smoker, he has a pretty good quality of life and he appears very well for his age. So, I would still recommend [LCS] to him.

BKA = below-knee amputation; CAD = coronary artery disease; CKD = chronic kidney disease; LCS = lung cancer screening.